Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Anthony M. Marchese, PhD

Senior Manager, Medical Affairs
Novavax, Inc.

Disclosure(s): Novavax Inc: Employee, Stocks/Bonds (Public Company)

Poster(s):

(P-607) Immunogenicity and Tolerability of the Novavax Nanoparticle Influenza Vaccine (NIV) and COVID-Influenza Combination Vaccine (CIC)

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-1949) The Self-Controlled Risk Interval: An Evolving Method for Vaccine Effectiveness Estimation in Complex Real-World Data

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
(P-1972) SARS-CoV-2 Vaccine–Induced IgG4 Response Negatively Correlates with Neutralizing Antibodies and Fc Effector Functions

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT